{"id":6876,"date":"2024-04-23T10:32:55","date_gmt":"2024-04-23T08:32:55","guid":{"rendered":"https:\/\/www.socesfar.es\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/"},"modified":"2024-04-23T10:32:56","modified_gmt":"2024-04-23T08:32:56","slug":"actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024","status":"publish","type":"revista","link":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/","title":{"rendered":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 22, n\u00ba 1, 2024"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/REVISTA-AFT-No22-1-MARZO-2024.pdf\">Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 22, n\u00ba 1, 2024<\/a><\/p>\n\n<p>Diez a\u00f1os de tratamiento de la hepatitis C con antivirales de acci\u00f3n directa<\/p>\n\n<p>EDITORIAL DEL PRESIDENTE DE LA SEF:<\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/01-EDITORIAL-DEL-PRESIDIENTE-SEF-XLI-CONGRESO-Y-OTRAS-COSAS-A-LA-VISTA.pdf\">Congreso, y otras cosas, a la vista.<\/a><\/p>\n\n<p>EDITORIAL DEL DIRECTOR:<\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/02-EDITORIAL-DEL-DIRECTOR-UNA-HISTORIA-DE-LA-FARMACOLOGIA-ESPANOLA.pdf\">Una historia de la farmacolog\u00eda espa\u00f1ola.<\/a><\/p>\n\n<p>EDITORIALES INVITADAS:<\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/03-EDITORIAL-INVITADO-PREMIO-NOBEL-DE-QUIMICA-2023-A-LOS-PUNTOS-CUANTICOS.pdf\">Premio Nobel de qu\u00edmica 2023 a los puntos cu\u00e1nticos. Un Descubrimiento Revolucionario con gran Impacto en la Ciencia y en la Sociedad.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/04-EDITORIAL-INVITADO-THE-REMARKABLE-SOCIAL-IMPACT-OF-CLINICALTRIALS-OF-COVID-19-DRUGS-AND-VACCINES.pdf\">The remarkable social impact of clinical trials of COVID-19 drugs and vaccines.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/05-EDITORIAL-INVITADO-ALZHEIMER-ENFERMEDAD-O-EFECTO-SECUNDARIO-NATURAL-DE-LA-EDAD.pdf\">\u201cAlzheimer\u201d, \u00bfenfermedad o efecto secundario natural de la edad?<\/a><\/p>\n\n<p>ARTICULO<\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/06-ARTICULO-DIEZ-ANOS-DE-TRATAMIENTO-DE-LA-HEPATITIS-C-CON-ANTIVIRALES-DE-ACCION-DIRECTA.pdf\">Diez a\u00f1os de tratamiento de la hepatitis C con antivirales de acci\u00f3n directa.<\/a><\/p>\n\n<p><a href=\"Asudexian: un nuevo anticoagulante oral de acci&#xF3;n directa.\">Asudexian: un nuevo anticoagulante oral de acci\u00f3n directa.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/08-ARTICULO-GLP-1-AGONISTS-IN-TYPE-2-DIABETES-MELLITUS-AND-BEYOND.pdf\">GLP-1 agonists in type 2 diabetes mellitus and beyond.<\/a><\/p>\n\n<p>FRONTERAS EN FARMACOTERAPIA:<\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/09-FRONTERAS-FARMACOTERAPIA-BERDAZIMER-NUEVO-FARMACO-PARA-EL-TRATAMIENTO-DEL-MOLUSCO-CONTAGIOSO-AUTORIZADO-POR-LA-FDA.pdf\">Berdazimer, nuevo f\u00e1rmaco para el tratamiento del molusco contagioso, autorizado por la FDA.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/10-FRONTERAS-FARMACOTERAPIA-APROBADO-EL-USO-DE-LA-TIRZEPATIDA-PARA-EL-TRATAMIENTO-DE-LA-OBESIDAD.pdf\">Aprobado el uso de la tirzepatida para el tratamiento de la obesidad.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/11-FRONTERAS-FARMACOTERAPIA-ENZALUTAMIDA-PARA-EL-TRATAMIENTO-DEL-CANCER-DE-PROSTATA-RECURRENTE.pdf\">Enzalutamida para el tratamiento del c\u00e1ncer de pr\u00f3stata recurrente.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/12-FRONTERAS-FARMACOTERAPIA-LA-ZOSURABALPINA-EL-NUEVO-ANTIBIOTICO-CONTRA-LAS-SUPERBACTERIAS.pdf\">La zosurabalpina, el nuevo antibi\u00f3tico contra las superbacterias.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/14-ENSAYOS-CLINICOS-COMENTADOS-CONTINUIDAD-DEL-TRATAMIENTO-CON-TIRZEPATIDA-PARA-MANTENER-LA-REDUCCION-DE-PESO-EN-ADULTOS-CON-OBESIDAD.pdf\">Continuidad del tratamiento con Tirzepatida para mantener la reducci\u00f3n de peso en adultos con obesidad.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/13-FRONTERAS-FARMACOTERAPIA-CAPIVASERTIB-PARA-EL-CANCER-DE-MAMA-AVANZADO-Y-METASTASICO.pdf\">Capivasertib para el c\u00e1ncer de mama avanzado y metast\u00e1sico.<\/a><\/p>\n\n<p>ENSAYOS CL\u00cdNICOS COMENTADOS<\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/14-ENSAYOS-CLINICOS-COMENTADOS-CONTINUIDAD-DEL-TRATAMIENTO-CON-TIRZEPATIDA-PARA-MANTENER-LA-REDUCCION-DE-PESO-EN-ADULTOS-CON-OBESIDAD.pdf\">Continuidad del tratamiento con Tirzepatida para mantener la reducci\u00f3n de peso en adultos con obesidad.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/15-ENSAYOS-CLINICOS-COMENTADOS-ENSAYOS-CLINICOS-A-TENER-EN-CUENTA-EN-2024.pdf\">Ensayos cl\u00ednicos a tener en cuenta en 2024.<\/a><\/p>\n\n<p>DOCENCIA EN FARMACOLOG\u00cdA<\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/16-DOCENCIA-EN-FARMACOLOGIA-FORMACION-MEDICA-CONTINUADA-EN-COMPETENCIAS-TRANSVERSALES.pdf\">Formaci\u00f3n m\u00e9dica continuada en competencias transversales: dos d\u00e9cadas de experiencia en cursos de formaci\u00f3n para profesionales sanitarios.<\/a><\/p>\n\n<p>EL F\u00c1RMACO Y LA PALABRA<\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/17-EL-FARMACO-Y-LA-PALABRA-LA-FELICIDAD-NO-ESTA-EN-EL-PASADO-NI-EN-EL-FUTURO.-ES-HOY.pdf\">La felicidad no est\u00e1 en el pasado ni en el futuro. Es ahora<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/18-CASOS-CLINICOS-FARMACOTERAPICOS.pdf\">CASOS CL\u00cdNICOS FARMACOTER\u00c1PICOS<\/a><\/p>\n\n<p>Subid\u00f3n de adrenalina.<\/p>\n\n<p>Centenaria fenito\u00edna.<\/p>\n\n<p>Boca seca.<\/p>\n\n<p>Anabolizantes y agresividad.<\/p>\n\n<p>Anticolinester\u00e1sicos.<\/p>\n\n<p>HAZTE SOCIO DE LA SEF<\/p>\n\n<p>NORMAS PARA LOS AUTORES<\/p>\n","protected":false},"featured_media":6868,"template":"","categoria_revista":[119],"class_list":["post-6876","revista","type-revista","status-publish","has-post-thumbnail","hentry","categoria_revista-2024-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 22, n\u00ba 1, 2024 - Sociedad Espa\u00f1ola de Farmacolog\u00eda<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 22, n\u00ba 1, 2024 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta property=\"og:description\" content=\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 22, n\u00ba 1, 2024 Diez a\u00f1os de tratamiento de la hepatitis C con antivirales de acci\u00f3n directa EDITORIAL DEL PRESIDENTE DE LA SEF: Congreso, y otras cosas, a la vista. EDITORIAL DEL DIRECTOR: Una historia de la farmacolog\u00eda espa\u00f1ola. EDITORIALES INVITADAS: Premio Nobel de qu\u00edmica 2023 a los puntos ... Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-23T08:32:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/foto-portada-revista-0424.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"610\" \/>\n\t<meta property=\"og:image:height\" content=\"356\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Socesfar\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/\",\"url\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/\",\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 22, n\u00ba 1, 2024 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"isPartOf\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/foto-portada-revista-0424.jpg\",\"datePublished\":\"2024-04-23T08:32:55+00:00\",\"dateModified\":\"2024-04-23T08:32:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/#primaryimage\",\"url\":\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/foto-portada-revista-0424.jpg\",\"contentUrl\":\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/foto-portada-revista-0424.jpg\",\"width\":610,\"height\":356},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.socesfar.es\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revistas\",\"item\":\"https:\/\/www.socesfar.es\/en\/revistas\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 22, n\u00ba 1, 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.socesfar.es\/en\/#website\",\"url\":\"https:\/\/www.socesfar.es\/en\/\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.socesfar.es\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.socesfar.es\/en\/#organization\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"url\":\"https:\/\/www.socesfar.es\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png\",\"contentUrl\":\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png\",\"width\":383,\"height\":63,\"caption\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\"},\"image\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/Socesfar\",\"https:\/\/www.linkedin.com\/company\/socesfar\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 22, n\u00ba 1, 2024 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/","og_locale":"en_US","og_type":"article","og_title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 22, n\u00ba 1, 2024 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","og_description":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 22, n\u00ba 1, 2024 Diez a\u00f1os de tratamiento de la hepatitis C con antivirales de acci\u00f3n directa EDITORIAL DEL PRESIDENTE DE LA SEF: Congreso, y otras cosas, a la vista. EDITORIAL DEL DIRECTOR: Una historia de la farmacolog\u00eda espa\u00f1ola. EDITORIALES INVITADAS: Premio Nobel de qu\u00edmica 2023 a los puntos ... Read more","og_url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/","og_site_name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","article_modified_time":"2024-04-23T08:32:56+00:00","og_image":[{"width":610,"height":356,"url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/foto-portada-revista-0424.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@Socesfar","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/","url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/","name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 22, n\u00ba 1, 2024 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","isPartOf":{"@id":"https:\/\/www.socesfar.es\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/#primaryimage"},"image":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/foto-portada-revista-0424.jpg","datePublished":"2024-04-23T08:32:55+00:00","dateModified":"2024-04-23T08:32:56+00:00","breadcrumb":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/#primaryimage","url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/foto-portada-revista-0424.jpg","contentUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2024\/04\/foto-portada-revista-0424.jpg","width":610,"height":356},{"@type":"BreadcrumbList","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-22-no-1-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.socesfar.es\/en\/"},{"@type":"ListItem","position":2,"name":"Revistas","item":"https:\/\/www.socesfar.es\/en\/revistas\/"},{"@type":"ListItem","position":3,"name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 22, n\u00ba 1, 2024"}]},{"@type":"WebSite","@id":"https:\/\/www.socesfar.es\/en\/#website","url":"https:\/\/www.socesfar.es\/en\/","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","description":"","publisher":{"@id":"https:\/\/www.socesfar.es\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.socesfar.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.socesfar.es\/en\/#organization","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","url":"https:\/\/www.socesfar.es\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","contentUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","width":383,"height":63,"caption":"Sociedad Espa\u00f1ola de Farmacolog\u00eda"},"image":{"@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/Socesfar","https:\/\/www.linkedin.com\/company\/socesfar\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/6876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista"}],"about":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/types\/revista"}],"version-history":[{"count":1,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/6876\/revisions"}],"predecessor-version":[{"id":6877,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/6876\/revisions\/6877"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/media\/6868"}],"wp:attachment":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/media?parent=6876"}],"wp:term":[{"taxonomy":"categoria_revista","embeddable":true,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/categoria_revista?post=6876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}